Stephen Michael Kelsey, See Remarks at Revolution Medicines, Inc. (RVMD), sold 92,531 shares at $198.55 ($18.7M) on 2026-09-11, disclosed to the SEC on 2026-09-15.
Scheduled sale ($18.7M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $198.55 | 800 | $159K | 0.8% |
| 2 | $200.11 | 11,833 | $2.4M | 12.6% |
| 3 | $200.78 | 13,368 | $2.7M | 14.3% |
| 4 | $201.75 | 21,447 | $4.3M | 23.1% |
| 5 | $203.06 | 18,869 | $3.8M | 20.5% |
| 6 | $203.87 | 17,949 |
| $3.7M |
| 19.5% |
| 7 | $204.84 | 4,995 | $1.0M | 5.5% |
| 8 | $205.81 | 3,270 | $673K | 3.6% |
| Total | $202.36 avg | 92,531 | $18.7M | 100% |
| Filing → |
| RVMD | SELL | 2026-03-19 | $856K | — | Filing → |
| RVMD | SELL | 2025-12-18 | $837K | — | Filing → |
| RVMD | SELL | 2025-10-15 | $1.2M | — | Filing → |